These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16216134)

  • 21. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Bellisai F; Rossi Paccani S; Laghi Pasini F; Capecchi PL; Sebastiani GD; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(4):1051-8. PubMed ID: 20074469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
    Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
    Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
    Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome.
    Stjernberg-Salmela S; Ranki A; Karenko L; Siitonen S; Mustonen H; Puolakkainen P; Sarna S; Pettersson T; Repo H
    Rheumatology (Oxford); 2010 Feb; 49(2):382-90. PubMed ID: 20071450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.
    Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L
    Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases.
    Masson C; Simon V; Hoppé E; Insalaco P; Cissé I; Audran M
    Joint Bone Spine; 2004 Jul; 71(4):284-90. PubMed ID: 15288852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family.
    Dinc A; Erdem H; Rowczenio D; Simsek I; Pay S; Bahce M; Lachmann H
    J Nephrol; 2005; 18(5):626-9. PubMed ID: 16299693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Quillinan N; Coughlan RJ; Church L; McDermott MF; Turner MD
    Arthritis Rheum; 2009 Feb; 60(2):619-25. PubMed ID: 19180495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoinflammatory diseases.
    Touitou I; Koné-Paut I
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):811-29. PubMed ID: 19028365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
    Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL
    Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
    Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
    Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
    Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
    Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
    Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
    J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-abdominal abscess in a patient with tumour necrosis factor receptor-associated periodic syndrome.
    Stjernberg-Salmela S; Kivisaari A; Puolakkainen P; Färkkilä M; Kemppainen E; Ranki A; Pettersson T
    J Intern Med; 2006 Feb; 259(2):209-13. PubMed ID: 16420550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome.
    Aganna E; Zeharia A; Hitman GA; Basel-Vanagaite L; Allotey RA; Booth DR; Hawkins PN; Thacker C; Syndercombe-Court D; McDermott MF
    Arthritis Rheum; 2002 Jan; 46(1):245-9. PubMed ID: 11817598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis.
    Aganna E; Hawkins PN; Ozen S; Pettersson T; Bybee A; McKee SA; Lachmann HJ; Karenko L; Ranki A; Bakkaloglu A; Besbas N; Topaloglu R; Hoffman HM; Hitman GA; Woo P; McDermott MF
    Genes Immun; 2004 Jun; 5(4):289-93. PubMed ID: 15071491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
    Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
    Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung Involvement in Children with Hereditary Autoinflammatory Disorders.
    Tarantino G; Esposito S; Andreozzi L; Bracci B; D'Errico F; Rigante D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
    Cudrici C; Deuitch N; Aksentijevich I
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.